Sphinx Pharmaceuticals Corp. of Durham, N.C., said Tuesdaythat it has begun a Phase II clinical trial of its lead product,Kynac ointment, for treating the signs and symptoms ofpsoriasis.
(c) 1997 American Health Consultants. All rights reserved.
Sphinx Pharmaceuticals Corp. of Durham, N.C., said Tuesdaythat it has begun a Phase II clinical trial of its lead product,Kynac ointment, for treating the signs and symptoms ofpsoriasis.
(c) 1997 American Health Consultants. All rights reserved.